150 related articles for article (PubMed ID: 19242039)
1. Disseminated lipogranulomatosis.
Mondal RK; Nandi M; Datta S; Hira M
Indian Pediatr; 2009 Feb; 46(2):175-7. PubMed ID: 19242039
[TBL] [Abstract][Full Text] [Related]
2. Farber disease: a rare neurodegenerative disorder.
Ahmad A; Mazhar AU; Anwar M
J Coll Physicians Surg Pak; 2009 Jan; 19(1):67-8. PubMed ID: 19149988
[TBL] [Abstract][Full Text] [Related]
3. Farber lipogranulomatosis with predominant joint involvement mimicking juvenile idiopathic arthritis.
Kostik MM; Chikova IA; Avramenko VV; Vasyakina LI; Le Trionnaire E; Chasnyk VG; Levade T
J Inherit Metab Dis; 2013 Nov; 36(6):1079-80. PubMed ID: 23385296
[TBL] [Abstract][Full Text] [Related]
4. Farber disease: report of three cases with joint involvement mimicking juvenile idiopathic arthritis.
Moghadam SH; Tavasoli AR; Modaresi M; Ziaee V
J Musculoskelet Neuronal Interact; 2019 Dec; 19(4):521-525. PubMed ID: 31789304
[TBL] [Abstract][Full Text] [Related]
5. Farber disease in infancy resembling juvenile idiopathic arthritis: identification of two new mutations and a good early response to allogeneic haematopoietic stem cell transplantation.
Torcoletti M; Petaccia A; Pinto RM; Hladnik U; Locatelli F; Agostoni C; Corona F
Rheumatology (Oxford); 2014 Aug; 53(8):1533-4. PubMed ID: 24614645
[No Abstract] [Full Text] [Related]
6. Farber lipogranulomatosis type 1--late presentation and early death in a Croatian boy with a novel homozygous ASAH1 mutation.
Cvitanovic-Sojat L; Gjergja Juraski R; Sabourdy F; Fensom AH; Fumic K; Paschke E; Levade T
Eur J Paediatr Neurol; 2011 Mar; 15(2):171-3. PubMed ID: 20609603
[TBL] [Abstract][Full Text] [Related]
7. Farber's disease (disseminated lipogranulomatosis): the first case reported in Japan.
Ozaki H; Mizutani M; Hayashi H; Oka E; Ohtahara S; Kimoto H; Tanaka T; Hakozaki H; Takahashi K; Suzuki Y
Acta Med Okayama; 1978 Apr; 32(1):69-79. PubMed ID: 148836
[TBL] [Abstract][Full Text] [Related]
8. Novel biochemical abnormalities and genotype in Farber disease.
Muranjan M; Agarwal S; Lahiri K; Bashyam M
Indian Pediatr; 2012 Apr; 49(4):320-2. PubMed ID: 22565078
[TBL] [Abstract][Full Text] [Related]
9. Nervous system involvement in Farber disease.
Cappellari AM; Torcoletti M; Triulzi F; Corona F
J Inherit Metab Dis; 2016 Jan; 39(1):149-50. PubMed ID: 26373951
[TBL] [Abstract][Full Text] [Related]
10. Optic Nerve Involvement in Farber Lipogranulomatosis: Expanding the Phenotypic Spectrum.
Alamri AS; Alshowaeir DA; AlFaiz AA; Al Mousawi FH; Mahmoud AA; Alhashim AH
J Neuroophthalmol; 2019 Sep; 39(3):391-393. PubMed ID: 31022067
[No Abstract] [Full Text] [Related]
11. A novel mutation in an atypical presentation of the rare infantile Farber disease.
Al Jasmi F
Brain Dev; 2012 Jun; 34(6):533-5. PubMed ID: 21982811
[TBL] [Abstract][Full Text] [Related]
12. Finger joint swellings in a teenager: juvenile rheumatoid arthritis or a psychiatric disorder?
Ostendorf B; Iking-Konert C; Cohnen M; Schneider M
Ann Rheum Dis; 2005 Mar; 64(3):501-2. PubMed ID: 15708904
[No Abstract] [Full Text] [Related]
13. Farber disease in a newborn.
Sana C; Larbi E; Samir A; Abdelhak B; Mustapha H
Pediatr Dermatol; 2009; 26(1):44-6. PubMed ID: 19250404
[TBL] [Abstract][Full Text] [Related]
14. Novel V97G ASAH1 mutation found in Farber disease patients: unique appearance of the disease with an intermediate severity, and marked early involvement of central and peripheral nervous system.
Chedrawi AK; Al-Hassnan ZN; Al-Muhaizea M; Colak D; Al-Younes B; Albakheet A; Tulba S; Kaya N
Brain Dev; 2012 May; 34(5):400-4. PubMed ID: 21893389
[TBL] [Abstract][Full Text] [Related]
15. Atypical presentation of infantile-onset farber disease with novel ASAH1 mutations.
Kim SY; Choi SA; Lee S; Lee JS; Hong CR; Lim BC; Kang HJ; Kim KJ; Park SH; Choi M; Chae JH
Am J Med Genet A; 2016 Nov; 170(11):3023-3027. PubMed ID: 27411168
[TBL] [Abstract][Full Text] [Related]
16. C26-Ceramide as highly sensitive biomarker for the diagnosis of Farber Disease.
Cozma C; Iurașcu MI; Eichler S; Hovakimyan M; Brandau O; Zielke S; Böttcher T; Giese AK; Lukas J; Rolfs A
Sci Rep; 2017 Jul; 7(1):6149. PubMed ID: 28733637
[TBL] [Abstract][Full Text] [Related]
17. Comparison of patients with juvenile psoriatic arthritis and nonpsoriatic juvenile idiopathic arthritis: how different are they?
Butbul YA; Tyrrell PN; Schneider R; Dhillon S; Feldman BM; Laxer RM; Saurenmann RK; Spiegel L; Cameron B; Tse SM; Silverman ED
J Rheumatol; 2009 Sep; 36(9):2033-41. PubMed ID: 19648305
[TBL] [Abstract][Full Text] [Related]
18. Early morphological diagnosis of Farber disease.
Nivaggioni V; Cano A; Arnoux I; Michel G; Loosveld M
Br J Haematol; 2016 Oct; 175(2):189. PubMed ID: 27471081
[No Abstract] [Full Text] [Related]
19. Acid Ceramidase Deficiency is characterized by a unique plasma cytokine and ceramide profile that is altered by therapy.
Dworski S; Lu P; Khan A; Maranda B; Mitchell JJ; Parini R; Di Rocco M; Hugle B; Yoshimitsu M; Magnusson B; Makay B; Arslan N; Guelbert N; Ehlert K; Jarisch A; Gardner-Medwin J; Dagher R; Terreri MT; Lorenco CM; Barillas-Arias L; Tanpaiboon P; Solyom A; Norris JS; He X; Schuchman EH; Levade T; Medin JA
Biochim Biophys Acta Mol Basis Dis; 2017 Feb; 1863(2):386-394. PubMed ID: 27915031
[TBL] [Abstract][Full Text] [Related]
20. A lipid metabolic disorder: disseminated lipogranulomatosis; a syndrome with similarity to, and important difference from, Niemann-Pick and Hand-Schüller-Christian disease.
FARBER S
AMA Am J Dis Child; 1952 Oct; 84(4):499-500. PubMed ID: 12975849
[No Abstract] [Full Text] [Related]
[Next] [New Search]
